Sizzling Stock Picks

[Stock Rockstar]

$TWSI = Mass Shooting Play

http://www.wallstreetnewscast.com/news/2015/12/twsi-5224.html

HemCon Bandages Offer Solution to "Stop the Bleed" Campaign
By: staff reporter, John Bodger
Last Updated: December 08, 2015 8:10 AM EST

(NEW YORK)--Tristar Wellness Solutions (OTCQB:TWSI), and their line of blood control bandages, may provide an excellent solution to the White House's new "Stop the Bleed" initiative.

In Oct. 2015, the White House launch a new campaign called "Stop the Bleed" to to provide bystanders and first responders with the tools and knowledge to stop life threatening bleeding at mass shootings or terrorist events.

Hemcon Medical, which is traded under the symbol TWSI, produces FDA approved ChitoGauze hemostatic chitosan-coated gauze, which doesn't only cover wounds, but also assists in controlling bleeding by producing clotting. (see video below)

HemCon blood control bandages have been effective in saving many US lives on the battlefields of Iraq, and now potentially for civilian use here in the homeland as well.

The plan is to have kits in most every government building, schools, or as part of work place first aid kits to assist bystanders and first responders in treating life threatening bleeding at the scene.

Uncontrolled bleeding injuries can result from natural and manmade disasters and from everyday accidents. If this bleeding is severe, it can kill within minutes, potentially before trained responders can arrive. Providing bystanders with basic tools and information on the simple steps they can take in an emergency situation to stop life threatening bleeding can save lives.

HemCon's blood control bandages can be purchased by government entities, such as military or municipalities, or individually online at such places as Amazon or their website for local local communities or offices looking to develop their own "Stop the Bleed" first aid kits.

On April 2014, TWSI announced that the U.S. Department of Defense's Committee on Tactical Combat Casualty Care (CoTCCC) updated its guideline recommendations for control of severe external hemorrhage, to include HemCon's ChitoGauze hemostatic chitosan-coated gauze product. Having the US Military recommending TWSI product as an effective means in blood control in emergency situations makes HemCon a real solution in the "Stop the Bleed" campaign.

HemCon currently has around 28 million shares issued and outstanding, and trades under the stock symbol "TWSI". Based on continued need for blood control bandages on the battlefield, and now for civilian use in the US, TWSI stock could see a sharp rise in sales interest in their blood control bandages. http://www.otcmarkets.com/stock/twsi/quote

About HemCon Medical Technologies, Inc.

HemCon Medical Technologies Inc., which is publicly traded under Tristar Wellness Solution (OTCQB:TWSI), develops, manufactures, and markets innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. HemCon products are designed for use by military and civilian first responders as well as medical professionals in hospital and clinical settings where control of bleeding are of critical importance. HemCon is headquartered in Portland, Ore. With a 36,000 sq. ft. state of the art manufacturing facility, the Company has additional commercial operations in Ireland and the Czech Republic. www.hemcon.com